Shilpa Medicare Partners NXI Therapeutics for Autoimmune Therapy Development, Manufacturing
New Delhi: Shilpa Medicare has announced the strategic partnership for a long-term development and commercial manufacturing agreement with NXI Therapeutics AG, Switzerland for a novel therapy targeting autoimmune and alloimmune…